Mapping large numbers of results may take a few moments.
|Company Dova Pharmaceuticals Inc.||Activity: Research and Development||Company Description Dova Pharmaceuticals, a subsidiary of Swedish Orphan Biovitrum AB (Sobi), develops treatments for orphan diseases. Its lead compound is a treatment for thrombocytopenia in patients with chronic liver disease.||Location Durham|
|Company HemoSonics LLC||Activity: Research and Development||Company Description HemoSonics is developing an in vitro diagnostic platform that measures the evolving stiffness of forming blood clots within a consumable test cartridge. Its technology assists with the management of coagulation dysfunctions at the point of care.||Location Durham|